Related Announcements

NOT-MD-22-001 - Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)

Issued by

National Institute on Minority Health and Health Disparities (NIMHD)

Purpose

The purpose of this Notice is to inform applicants of a change in the eligibility to be a Principal Investigator (PI) of a pilot project funded through NOT-MD-22-001, "Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)."

Effective immediately, the following sections of NOT-MD-22-001 have been modified, as indicated below.

Currently Reads:

Purpose

This Notice of Special Interest (NOSI) invites applications for administrative supplements to NIMHD Research Centers in Minority Institutions (RCMI) U54 awards to support pilot research projects led by early-stage investigators (ESIs) focused on research on substance use, addiction, and/or neuroscience, as a bridge to independently funded careers. To help achieve this goal, it is expected that pilot project PIs will prepare and submit follow-up research grant or career development applications to NIH based on the research supported by these supplemental funds.

Background

Research Objectives

Supplements awarded through this NOSI are intended to provide support to early career investigators to conduct pilot studies in the areas of substance abuse, addiction and neuroscience research and collect data they can use to prepare for applications for independent funding. The proposed research can range from basic, to clinical, translation, epidemiology, services, and prevention, but must be relevant to the NIDA mission (see https://www.drugabuse.gov/about-nida/strategic-plan/executive-summary).

Eligibility to be a PI of a pilot project funded through this NOSI is limited to early-stage investigators (ESIs) as defined by NIH (https://grants.nih.gov/policy/early-investigators/index.htm) with their primary appointment at an RCMI U54 recipient institution. ESI PIs should be positioned to submit an NIH grant application within two years of the supplement award date. Individuals from underrepresented groups, individuals with disabilities, and individuals from disadvantaged backgrounds are strongly encouraged to apply as PIs. Recipients will be invited to participate in NIDA-sponsored professional development activities.

Applications not responsive to this NOSI:

• Projects supplementing awards that are not eligible under this NOSI.
• Projects not supporting pilot research projects led by early-stage investigators (ESIs) at the senior post-doctoral or fellowship level or assistant professor conducting substance use, addiction, and related neuroscience research with their primary appointment at an RCMI U54 recipient institution.
• Projects not addressing outreach and recruitment strategies to ensure that investigators from underrepresented backgrounds are in the pool of pilot PI applicants.
• Projects conducting research outside of the U.S. or its territories and possessions, the Commonwealth of Puerto Rico, or the Trust Territory of the Pacific Islands, or requesting foreign components.

Modified to Read (changes shown in bold italics):

Purpose

This Notice of Special Interest (NOSI) invites applications for administrative supplements to NIMHD Research Centers in Minority Institutions (RCMI) U54 awards to support pilot research projects led by early-stage investigators (ESIs) and new investigators (NIs) focused on research on substance use, addiction, and/or neuroscience, as a bridge to independently funded careers. To help achieve this goal, it is expected that pilot project PIs will prepare and submit follow-up research grant or career development applications to NIH based on the research supported by these supplemental funds.

Background

Research Objectives

Supplements awarded through this NOSI are intended to provide support to ESIs and NIs to conduct pilot studies in the areas of substance abuse, addiction and neuroscience research and collect data they can use to prepare for applications for independent funding. The proposed research can range from basic, to clinical, translation, epidemiology, services, and prevention, but must be relevant to the NIDA mission (see https://www.drugabuse.gov/about-nida/strategic-plan/executive-summary).

Eligibility to be a PI of a pilot project funded through this NOSI is limited to ESIs as defined by NIH (https://grants.nih.gov/policy/early-investigators/index.htm) and NIs with their primary appointment at an RCMI U54 recipient institution. NIs are defined by NIH as individuals who have not previously competed successfully for substantial, independent funding from NIH. Investigators maintain NI status if they have received any of the smaller research grants, training, infrastructure, and career awards that appear on this list: https://grants.nih.gov/policy/early-investigators/list-smaller-grants.htm. ESI and NI PIs should be positioned to submit an NIH grant application within two years of the supplement award date. Individuals from underrepresented groups, individuals with disabilities, and individuals from disadvantaged backgrounds are strongly encouraged to apply as PIs. Recipients will be invited to participate in NIDA-sponsored professional development activities.

Applications not responsive to this NOSI:

• Projects supplementing awards that are not eligible under this NOSI.
• Projects not supporting pilot research projects led by ESIs or NIs conducting substance use, addiction, and related neuroscience research with their primary appointment at an RCMI U54 recipient institution.
• Projects not addressing outreach and recruitment strategies to ensure that investigators from underrepresented backgrounds are in the pool of pilot PI applicants.
• Projects conducting research outside of the U.S. or its territories and possessions, the Commonwealth of Puerto Rico, or the Trust Territory of the Pacific Islands, or requesting foreign components.

All other aspects of this Funding Opportunity Announcement (FOA) remain the same.

Inquiries

Please direct all inquiries to:

Nathan Stinson, Jr, PhD, MD, MPH
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8704
E-mail: nathaniel.stinson@nih.gov